These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 32665857)

  • 1. Corrigendum to: Association between matrix Gla protein and ulcerative colitis according to DNA microarray data.
    Dong XY; Wu MX; Zhang HM; Lyu H; Qian JM; Yang H
    Gastroenterol Rep (Oxf); 2020 Jun; 8(3):252. PubMed ID: 32665857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between matrix Gla protein and ulcerative colitis according to DNA microarray data.
    Dong XY; Wu MX; Zhang HM; Lyu H; Qian JM; Yang H
    Gastroenterol Rep (Oxf); 2020 Feb; 8(1):66-75. PubMed ID: 32257220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: Unveiling the key genes, environmental toxins, and drug exposures in modulating the severity of ulcerative colitis: a comprehensive analysis.
    Wang Y; Zhuang H; Jiang XH; Zou RH; Wang HY; Fan ZN
    Front Immunol; 2023; 14():1323997. PubMed ID: 38045682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer.
    Zhang C; Zhang J; Zhang Y; Song Z; Bian J; Yi H; Ma Z
    Front Immunol; 2024; 15():1376797. PubMed ID: 38660295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum to: Providing Hospitalized Ulcerative Colitis Patients With Practice Guidelines Improves Patient-Reported Outcomes.
    J Can Assoc Gastroenterol; 2021 Aug; 4(4):198. PubMed ID: 34337320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "A Rare Case of New-Onset Ulcerative Colitis following Initiation of Secukinumab".
    Achufusi TG; Harne PS; Rawlins S
    Case Rep Med; 2019; 2019():3689298. PubMed ID: 31827522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: The Extracts of
    Liang J; Liang J; Hao H; Lin H; Wang P; Wu Y; Jiang X; Fu C; Li Q; Ding P; Liu H; Xiong Q; Lai X; Zhou L; Chan S; Hou S
    Front Immunol; 2020; 11():2092. PubMed ID: 33042122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: [Corrigendum] Changes in expression of p53 and inflammatory factors in patients with ulcerative colitis.
    Su H; Kang Q; Wang H; Yin H; Duan L; Liu Y; Fan R
    Exp Ther Med; 2024 Mar; 27(3):96. PubMed ID: 38356675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Risks, precipitants and clinical presentation of gastro-oesophageal reflux disease at the Kilimanjaro Christian Medical Centre in Tanzania.
    Mwandri MB; Mwita JC; Magafu MG; Kilonzo KG; Urasa SJ
    Pan Afr Med J; 2015; 20():351. PubMed ID: 25918578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to: Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis.
    Kierkus J; Pesegova M; Klopocka M; Brankovic M; Kasai N; Efuni S; Kong J; Nakajima Y; Jordan C; Matsui T; Feagan BG; Strout V
    Crohns Colitis 360; 2020 Oct; 2(4):otaa092. PubMed ID: 36780244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of iNOS and elevation of cAMP mediate the anti-inflammatory effect of glabridin in rats with ulcerative colitis.
    El-Ashmawy NE; Khedr NF; El-Bahrawy HA; El-Adawy SA
    Inflammopharmacology; 2018 Apr; 26(2):551-559. PubMed ID: 28707183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between matrix Gla protein and clinical features of ulcerative colitis].
    Dong XY; Wu MX; Bai XY; Zhang HM; Yang H; Qian JM
    Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(44):3504-3509. PubMed ID: 33256292
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum: Biomarkers and Microscopic Colitis: An Unmet Need in Clinical Practice.
    Pisani LF; Tontini GE; Marinoni B; Villanacci V; Bruni B; Vecchi M; Pastorelli L
    Front Med (Lausanne); 2020; 7():4. PubMed ID: 32083085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: A Review: The Fate of Bacteriocins in the Human Gastro-Intestinal Tract: Do They Cross the Gut-Blood Barrier?
    Dicks LMT; Dreyer L; Smith C; van Staden AD
    Front Microbiol; 2018; 9():2938. PubMed ID: 30546355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to: Routine imaging of the preterm neonatal brain.
    Paediatr Child Health; 2021 Jul; 26(4):259. PubMed ID: 34131460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAs.
    Ranjha R; Meena NK; Singh A; Ahuja V; Paul J
    PLoS One; 2017; 12(9):e0184701. PubMed ID: 28880912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies.
    Motoya S; Watanabe M; Kim HJ; Kim YH; Han DS; Yuasa H; Tabira J; Isogawa N; Arai S; Kawaguchi I; Hibi T
    Intest Res; 2018 Jul; 16(3):499-501. PubMed ID: 30090051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: Impact of Opioid Consumption in Patients With Functional Gastrointestinal Disorders Research Topic: Pharmacological Treatments Affecting Gastro-Intestinal Motility in Man.
    Melchior C; Desprez C; Wuestenberghs F; Leroi AM; Lemaire A; Gourcerol G
    Front Pharmacol; 2021; 12():652927. PubMed ID: 33986680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Critical Role of Alternative M2 Skewing in miR-155 Deletion-Mediated Protection of Colitis.
    Li J; Zhang J; Guo H; Yang S; Fan W; Ye N; Tian Z; Yu T; Ai G; Shen Z; He H; Yan P; Lin H; Luo X; Li H; Wu Y
    Front Immunol; 2019; 10():3153. PubMed ID: 32117209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: Resveratrol Alleviates Dextran Sulfate Sodium-Induced Acute Ulcerative Colitis in Mice by Mediating PI3K/Akt/ VEGFA Pathway.
    Frontiers Production Office
    Front Pharmacol; 2021; 12():797101. PubMed ID: 34795595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.